Trial reportBMC anesthesiology2026
Effects of opioid-free anesthesia on postoperative anxiety in patients undergoing modified radical mastectomy for breast cancer: a randomized controlled trial.
Trial report in BMC anesthesiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
backgroundOpioid-free anesthesia (OFA) improves somatic recovery after breast cancer surgery, but its effect on postoperative anxiety has not been evaluated. We hypothesized that OFA would reduce postoperative state anxiety in patients undergoing modified radical mastectomy.
methodsIn this single-center, randomized, participant- and assessor-blinded trial, 106 patients undergoing modified radical mastectomy were assigned to OFA (n = 53) or opioid-based anesthesia (OA; n = 53). Both groups received a serratus anterior plane block. The OFA group received dexmedetomidine and esketamine intraoperatively and esketamine-based postoperative patient-controlled analgesia; the OA group received intraoperative opioids and sufentanil-based postoperative patient-controlled analgesia. The primary outcome was the State Anxiety Inventory (SAI) score 24 h after surgery. Secondary outcomes were exploratory.
resultsPreoperative SAI scores were comparable between groups. Postoperative SAI scores were significantly lower with OFA at 24 hours (median, 41 vs. 48; P < 0.001) and 72 hours (41.43 ± 4.53 vs. 45.55 ± 4.37; P < 0.001). The QoR-15 score at 24 hours was higher with OFA (median, 104 vs. 99; P < 0.001). NRS pain scores showed a modest rightward distributional shift with OFA at postoperative 24 hours (median, 3[3-4] vs. 3[3-3]; P = 0.014) but were significantly lower at postoperative 72 hours (median, 1 vs. 2; P < 0.001). The incidence of postoperative nausea and vomiting (PONV) was lower with OFA (13.21% vs. 32.08%; P = 0.020). Time to tracheal extubation and PACU length of stay were shorter with OFA (both P < 0.001). Intraoperative hemodynamic parameters and other adverse event rates did not differ significantly between groups.
conclusionsThe evaluated multicomponent opioid-free perioperative regimen reduced early postoperative state-anxiety scores compared with the opioid-based regimen. Because intraoperative drugs and postoperative analgesia differed between groups, the effects of opioid avoidance cannot be disentangled from the direct effects of dexmedetomidine, esketamine, or postoperative PCIA. The clinical importance and longer-term durability of the observed anxiety difference require confirmation.
trial registrationChiCTR2500101756, 04/29/2025.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.